wins US FDA approval for Imcivree (Setmelanotide) as the first treatment for acquired hypothalamic obesity, delivering 18.4% PBO-adjusted BMI reduction in P-III trial Subscribe to our weekly newsletter and never miss a beat: #rhythmpharmaceuticals #usfda #approval #imcivree #setmelanotide #acquiredhypothalamicobesity #piii #transcend #regulatory To view or add a comment, sign in Indias semaglutide moment is closer than it looks
Progressive overload (gradually increasing weight or reps) maintains the adaptive signal
This argues that the company either knew or should have known about the risk of the particular injury
This medication can be a game-changer for those of us struggling with weight loss, providing not just physical benefits but also emotional support through improved self-esteem and overall well-being
Brain slice electrophysiology Mice were anaesthetized with isoflurane and then perfused with ice-cold oxygenated N-Methyl-D-glucamine (NMDG) artificial cerebrospinal fluid (ACSF) (20 mL) that contained (in mM): KCl (2.5), NMDG (93), NaHCO (30), NaHPO (1.2), glucose (25), HEPES (20), thiourea (2), Na-pyruvate (3), CaCl (0.5), Na-ascorbate (5), MgSO (10), and glutathione (3) (pH 7.37.4, 300305 mOsm)
In the meantime, creative market solutions can expand access to these drugs
